Nuclear factors that bind to the U3 region of two murine myeloid leukemia-inducing retroviruses, Cas-Br-E and Graffi

Virology

Volumn 252, Issue 1, 1998, Pages 82-95

  Barat, Corinne ^a   Rassart, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Cas Br E MuLV; DNA binding protein; Graffi MuLV; Regulatory element

Indexed keywords

NUCLEAR FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL SPECIFICITY; GENE LOCATION; LATENT PERIOD; LEUKEMOGENESIS; LONG TERMINAL REPEAT; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; RETROVIRUS; TARGET CELL; TISSUE SPECIFICITY; VIRUS REPLICATION;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0032488257     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9435     Document Type: Article

References (73)

1. Andrews N. C., Faller D. V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of cells. Nucleic Acids Res. 19:1991;2499.
2. Barat C., Rassart E. Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and Graffi retroviruses and transactivate their expression. J. Virol. 72:1998;5579-5588.
3. Ben-David Y., Giddens E. B., Bernstein A. Identification and mapping of a common proviral integration siteFli-1. Proc. Natl. Acad. Sci. USA. 87:1990;1332-1336.
4. Ben-David Y., Giddens E. B., Letwin K., Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:1991;908-918.
5. Bergeron D., Barbeau B., Leger, Rassart E. Experimental bias in the evaluation of the cellular transient expression. Cell. Mol. Biol. Res. 41:1995;155-159.
6. Bergeron D., Houde J., Poliquin L., Barbeau B., Rassart E. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E- induced non-T-, non-B-cell leukemias. Leukemia. 7:1993;954-962.
7. Bergeron D., Poliquin L., Houde J., Barbeau B., Rassart E. Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-E MuLV-induced non-T-, non-B-cell leukemias. Virology. 191:1992;661-669.
8. Boral A. L., Okenquist S., Lenz J. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63:1989;76-84.
9. Bosze Z., Thiesen H., Charnay P. A transcriptional enhancer with specificity for erythroid cells is located in the long terminal repeat of the Friend murine leukemia virus. EMBO J. 5:1986;1615-1623.
10. Bryant M. L., Scott J. L., Pall B. K., Estes J. D., Gardner M. B. Immunopathology of natural and experimental lymphomas induced by wild mouse leukemia virus. Am. J. Pathol. 104:1981;272-282.
11. Chen H. M., Yoshimura F. K. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities. J. Virol. 68:1994;3308-3316.
12. DesGroseillers L., Jolicoeur P. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:1984;945-952.
13. DesGroseillers L., Jolicoeur P. Mapping the viral sequences conferring leukemogenicity and diseases pecificity in Moloney and amphotropic murine leukemia viruses. J. Virol. 52:1984;448-456.
14. DesGroseillers L., Rassart E., Jolicoeur P. Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. US. 80:1983;4203-4207.
15. Flanagan J. R., Krieg A., Max E., Khan A. S. Negative control region at the 5′ end of murine leukemia virus long terminal repeats. Mol. Cell. Biol. 66:1989;739-746.
16. Gama-Sosa M. A., Rosas D., DeGasperi E., Morita M., Hutchison M., Ruprecht R. M. Negative regulation of the 5′ long terminal repeat (LTR) by the 3′ LTR in the murine proviral genome. J. Virol. 68:1994;2662-2670.
17. Golemis E. A., Li Y., Fredrickson T., Hartley J., Hopkins N. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63:1989;328-337.
18. Golemis E. A., Speck N. A., Hopkins N. Alignment of U3 region sequences of mammalian type C viruses: Identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:1990;534-542.
19. Gorman C., Moffat L., Howard B. Mol. Cell. Biol. 2:1982;1044.
20. Gorska-Flipot I., Jolicoeur P. DNA-binding proteins that interact with the long terminal repeat of radiation leukemia virus. J. Virol. 64:1990;1566-1572.
21. Gottschalk L. R., Leiden J. M. Identification and functional characterization of the human T-cell receptor beta gene transcriptional enhancer: common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor alpha and beta genes. Mol. Cell. Biol. 10:1990;5486-5495.
22. Hanecak R., Pattengale P., Fan H. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus. J. Virol. 65:1991;5357-5363.
23. Hollon T., Yoshimura F. K. Mapping of functional regions of murine retrovirus long terminal repeat enhancers: Enhancer domains interact and are not independent in their contributions to enhancer activity. J. Virol. 63:1989;3353-3361.
24. Ishimoto A., Adachi A., Sakai K., Matsuyama M. Long terminal repeat of Friend-MCF virus contains the sequence responsible for erythroid leukemia. Virology. 141:1985;30-42.
25. Ishimoto A., Takimoto M., Adachi A., Kakuyama M., Kato S., Kakimi K., Fukuoka K., Ogiu T., Matsuyama M. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. J Virol. 61:1987;1861-1866.
26. Jolicoeur P., DesGroseillers L. Neurotropic Cas-BR-E murine leukemia virus harbors several determinants of leukemogenicity mapping in different regions of the genome. J. Virol. 56:1985;639-643.
27. Jolicoeur P., Rassart E., DesGroseillers L., Robitaille Y., Paquette Y., Kay D. G. Amyotrophic Lateral Sclerosis. 1991;Raven Press, New York. p. 481-493.
28. Lawrenz-Smith S. C., Massey A. C., Innes D., Thomas C. Y. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice. J. Virol. 68:1994;5174-5183.
29. Lawrenz-Smith S. C., Thomas C. Y. The E47 transcription factor binds to the enhancer sequences of recombinant murine leukemia viruses and influences enhancer function. J. Virol. 69:1995;4142-4148.
30. Lee M. C., Hapel A. J., Ihle J. N. Constitutive production of a unique lymphokine (IL3) by the WEHI-3 cell line. J. Immunol. 128:1982;2393-2398.
31. LoSardo J. E., Cupelli L., Short M., Bernard J., Lenz J. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells. J. Virol. 63:1989;1087-1094.
32. Manley N. R., O'Connell M., Sharp P., Hopkins N. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus. J. Virol. 63:1989;4210-4223.
33. Manley N. R., O'Connell M., Sun W., Speck N. A., Hopkins N. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers. J. Virol. 67:1993;1967-1975.
34. Massey A. C., Coppola M., Thomas C. Y. Origin of pathogenic determinants of recombinant murine leukemia viruses: analysis of Bxv-1-related xenotropic viruses from CWD mice. J. Virol. 64:1990;5491-5499.
35. Massey A. C., Lawrenz-Smith S. C., Innes D., Thomas C. Y. Origins of enhancer sequences of recombinant murine leukemia viruses from spontaneous B- and T-cell lymphomas of CWD mice. J. Virol. 68:1994;3773-3783.
36. Morrison H. L., Soni B., Lenz J. Long terminal repeat enhancer core sequences in proviruses adjacent toc-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:1995;446-455.
37. Muller R., Muller D. Co-transfection of normal NIH/3T3 DNA and retroviral LTR sequences:Aa novel strategy for the detection of potential c-onc genes. EMBO J. 3:1984;1121-1127.
38. Nielsen A. L., Pallisgaard N., Pedersen F. S., Jorgensen P. Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning. Mol. Cell. Biol. 12:1992;3449-3459.
39. Nielsen A. L., Pallisgaard N., Pedersen F. S., Jorgensen P. Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J. Virol. 68:1994;5638-5647.
40. Nieves A., Levy L. S., Lenz J. Importance of a c-myb binding site for lymphomagenesis by the retrovirus SL3-3. J. Virol. 71:1997;1213-1219.
41. Nuchprayoon I., Meyers S., Scott L. M., Suzow J., Hiebert S. W., Friedman A. D. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBFbeta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14:1994;5558-5568.
42. Okuda T., van-Deursen S., Hiebert S. W., Grosveld G., Downing J. R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
43. Oliff A. I., Hager G. L., Chang E. H., Scolnick E. M., Chan H. W., Lowy D. R. Transfection of molecularly cloned Friend murine leukemia virus DNA yields a highly leukemogenic helper independent type C virus. J. Virol. 33:1980;475-486.
44. Paquette Y., Hanna Y., Savard P., Brousseau R., Robitaille Y., Jolicoeur P. Retrovirus-induced murine motor neuron disease: Mapping the determinant of spongiform degeneration within the envelope gene. Proc. Natl. Acad. Sci, USA. 86:1989;3896-3900.
45. Paquette Y., Kay D., Rassart E., Robitaille Y., Jolicoeur P. Substitution of the U3 long terminal repeat region of the neurotropic Cas-Br-E retrovirus affects its disease-inducing potential. J. Virol. 64:1990;3742-3752.
46. Rassart E., Houde J., Denicourt C., Ru M., Barat C., Edouard E., Poliquin L., Bergeron D. Molecular analysis and characterization of two myeloid leukemia inducing murine retroviruses. Curr. Topics Microbiol. Immunol. 211:1996;201-210.
47. Rassart E., Nelbach L., Jolicoeur P. Cas-Br-E murine leukemia virus: sequencing of the paralytogenic region of its genome and derivation of specific probes to study its origin and the structure of its recombinant genomes in leukemic tissues. J. Virol. 60:1986;910-919.
48. Rassart E., Shang M., Boie Y., Jolicoeur P. Studies on emerging radiation leukemia virus variants in C57BL/Ka mice. J. Virol. 58:1986;96-106.
49. Redondo J. M., Pfohl J., Hernandez-Munain C., Wang S., Speck N. A., Krangel M. S. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Mol. Cell. Biol. 12:1992;4817-4823.
50. Ru M., Shustik C., Rassart E. Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent. J. Virol. 67:1993;4722-4731.
51. Sambrook J., Fritsh E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
52. Satyamoorthy K., Park K., Atchison M., Howe C. C. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct. Mol. Cell. Biol. 13:1993;6621-6628.
53. Savard P., DesGroseillers L., Rassart E., Poirier Y., Jolicoeur P. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma. J. Virol. 61:1987;3266-3275.
54. Short M. K., Okenquist S., Lenz J. Correlation of leukemogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats. J. Virol. 61:1987;1067-1072.
55. Speck N. A., Baltimore D. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1987;1101-1110.
56. Speck N. A., Renjifo B., Golemis E. A., Fredrickson T., Hartley J., Hopkins N. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:1990;233-242.
57. Speck N. A., Renjifo B., Hopkins N. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. J. Virol. 64:1990;543-550.
58. Sterneck E., Muller D., Katz R. L., Leutz A. Autocrine growth induced by kinase type oncogenes in myeloid cells requires. EMBO J. 11:1992;115-126.
59. Sun W., Graves B. J., Speck N. A. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. J. Virol. 69:1995;4941-4949.
60. Suzow J., Friedman A. D. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol. Cell. Biol. 13:1993;2141-2151.
61. Takahashi A., Satake M., Yamaguchi-Iwai Y., Bae S. C., Lu J., Maruyama M., Zhang Y. W., Oka H., Arai N., Arai K. Positive and negative regulation of granulocyte-macrophage colony- stimulating factor promoter activity by AML1-related transcription factor, PEBP2. J. Virol. 86:1995;607-616.
62. Thornell A., Hallberg B., Grundstrom T. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8:1988;1625-1637.
63. Tsukiyama T., Niwa O., Yokoro K. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Mol. Cell. Biol. 9:1989;4670-4676.
64. Tupper J. C., Chen H. M., Hays E., Bristol G., Yoshimura F. K. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer. J. Virol. 66:1992;7080-7088.
65. Wall L., deBoer E., Grosveld F. The human beta-globin gene 3′ enhancer contains multiple binding sites for an erythroid-specific protein. Genes Dev. 2:1988;1089-1100.
66. Wang S. W., Speck N. A. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12:1992;89-102.
67. Yoshimura F. K., Diem K. Characterization of nuclear protein binding to a site in the long terminal repeat of a murine leukemia virus: Comparison with the NFAT complex. J. Virol. 69:1995;994-1000.
68. Yoshimura F. K., Diem K., Chen H. M., Tupper J. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes. J. Virol. 67:1993;2298-2304.
69. Yuen P. H., Khang Y., Matherne C. Virulence in lymphomagenesis is modulated by alterations in proteins binding to CORE and GRE-LVa elements of the MoMuLV enhancer. Leukemia. 6:1992;76S-82S.
70. Zaiman A. L., Lenz J. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb. J. Virol. 70:1996;5618-5629.
71. Zaiman A. L., Lewis A., Crute B., Speck N. A., Lenz J. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores. J. Virol. 69:1995;2898-2906.
72. Zhang D. E., Fujioka K., Hetherington C., Shapiro L., Chen H. M., Look A., Tenen D. G. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14:1994;8085-8095.
73. Zhang D. E., Hetherington C., Meyers S., Rhoades K., Larson C., Chen H. M., Hiebert S. W., Tenen D. G. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16:1996;1231-1240.